Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 May;95(5):2180-6.
doi: 10.1210/jc.2009-2651. Epub 2010 Mar 12.

Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels

Helen Anderson  1 , Naomi Fogel, Stefan K Grebe, Ravinder J Singh, Robert L Taylor, Andrea Dunaif
Affiliations

Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels

Helen Anderson et al. J Clin Endocrinol Metab. 2010 May.

Abstract

Context: Prenatal androgen excess can cause a phenocopy of polycystic ovary syndrome (PCOS) in mammals. Retrospective studies have suggested that girls at risk for PCOS have low birth weight, and prospective studies have suggested an increased prevalence of small-for-gestational-age offspring in women with PCOS.

Objective: The objective of the study was to determine whether infants of women with PCOS have reduced birth weight or increased intrauterine androgen levels.

Design: This was a prospective case-control study.

Participants: Thirty-nine PCOS and 31 control women and their infants participated in the study.

Main outcome measures: Birth weight and mixed cord blood testosterone, androstenedione (A), dehydroepiandrosterone, 17-hydroxyprogesterone, estradiol (E2), and dihydrotestosterone levels were measured.

Results: Mean birth weight did not differ, but there was a significant increase in the prevalence of large-for-gestational-age infants in the PCOS group. Cord blood E2 and A levels were lower (P < 0.05), but testosterone to E2 ratios did not differ in female PCOS compared with control offspring. There was no difference in E2 and A levels in the male PCOS and control offspring. There was no difference in 17-hydroxyprogesterone or other androgen levels in either male or female PCOS offspring compared with their respective control group.

Conclusion: Infants of women with PCOS were more likely to be large for gestational age. Female offspring of affected women have lower cord blood A levels; other cord blood androgen levels do not differ compared with female control offspring. Cord blood E2 levels are also significantly decreased in PCOS, without any difference in the testosterone to E2 ratio, suggesting decreased fetal or placental production of steroids.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The prevalence of SGA, appropriate for gestational age (AGA), and LGA infants in PCOS (black bars) compared with control (open bars) offspring. There is a significant increase in PCOS LGA infants (P < 0.05).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ehrmann DA 2005 Polycystic ovary syndrome. N Engl J Med 352:1223–1236 - PubMed
    1. Urbanek M, Sam S, Legro RS, Dunaif A 2007 Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype. J Clin Endocrinol Metab 92:4191–4198 - PubMed
    1. Biyasheva A, Legro RS, Dunaif A, Urbanek M 2009 Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2. J Clin Endocrinol Metab 94:2617–2625 - PMC - PubMed
    1. Eagleson CA, Gingrich MB, Pastor CL, Arora TK, Burt CM, Evans WS, Marshall JC 2000 Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab 85:4047–4052 - PubMed
    1. Coviello AD, Legro RS, Dunaif A 2006 Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab 91:492–497 - PubMed

Publication types

MeSH terms